Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Orphan Drugs | Contract Pharma

What are you searching for?

Sign in

Orphan Drugs

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Drugs developed for rare diseases and conditions which, in the U.S., affect fewer than 200,000 people or which, in the EU, affect five or fewer per 10,000 people. Because sales of orphan drugs are likely to be small compared to their development costs, pharmaceutical companies are awarded exclusive rights to market these medicines for a period of time (usually seven years) as an incentive to develop them and bring them to market.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters